Gold Nanoparticle-Mediated Gene Therapy

49Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

Abstract

Gold nanoparticles (AuNPs) have gained increasing attention as novel drug-delivery nanostructures for the treatment of cancers, infections, inflammations, and other diseases and disorders. They are versatile in design, synthesis, modification, and functionalization. This has many advantages in terms of gene editing and gene silencing, and their application in genetic illnesses. The development of several techniques such as CRISPR/Cas9, TALEN, and ZFNs has raised hopes for the treatment of genetic abnormalities, although more focused experimentation is still needed. AuNPs, however, have been much more effective in trending research on this subject. In this review, we highlight recently well-developed advancements that are relevant to cutting-edge gene therapies, namely gene editing and gene silencing in diseases caused by a single gene in humans by taking an edge of the unique properties of the AuNPs, which will be an important outlook for future research.

Cite

CITATION STYLE

APA

Kanu, G. A., Parambath, J. B. M., Abu Odeh, R. O., & Mohamed, A. A. (2022, November 1). Gold Nanoparticle-Mediated Gene Therapy. Cancers. MDPI. https://doi.org/10.3390/cancers14215366

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free